Ledger.Open graph →

SEC Form D · filed December 14, 2022

THERALINK TECHNOLOGIES, INC

Offering

$3.4M

Sold

—

Exemption

Rule 506(c)

Industry

Biotechnology

Location

GOLDEN, CO

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (17)

Andrew W. Kucharchuk · Golden, CODirector Jeffrey Busch · Golden, CODirector Yvonne Fors · Golden, CODirector Danica Holley · Golden, CODirector Thomas W. Chilcott · Golden, COExec Michael Narea · Dover, DEDirector Joseph S. Caruso · Philadelphia, PADirector William Simon · NEW YORK, NYDirector Matthew W. Schwartz, Md · Golden, CODirector Mick Ruxin · Golden, COExec · Director Cynthia H. Davis · Charleston, SCDirector Charles-Antoine D. Lussier · Montreal, Quebec, CanadaDirector Greg Mcparland · Plymouth, MIDirector Matthew W. Schwartz, Md · Golden, CODirector Mick Ruxin · Golden, COExec · Director Danica Holley · Golden, CODirector Thomas W. Chilcott · Golden, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗